
9th International Conference on Bioscience & Engineering (BIEN 2026)
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 9th International Conference on Bioscience & Engineering (BIEN 2026) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
9th International Conference on Bioscience & Engineering (BIEN 2026)
Date: November 15–18, 2026
Venue: ExCeL London, London, United Kingdom
Event Type: Academic & Research, Biotechnology, Engineering Innovations, Healthcare Technologies, Agricultural Biotechnology, Environmental Science
Estimated Attendance: 1,500+ global participants, including researchers, academics, industry professionals, students, healthcare experts, and policymakers.
1️⃣ Who Attends (BUYERS / ATTENDEES)
- Academic researchers and professors from universities and research institutions
- Biotech and pharmaceutical industry executives (R&D, product development, business strategy)
- Healthcare professionals and clinical researchers
- Government and regulatory affairs specialists
- Startup founders and venture capitalists in bioscience and engineering
- Students and postdoctoral researchers in STEM fields
- Equipment and technology suppliers (lab instruments, software, AI-driven diagnostics)
2️⃣ Location + Attendee Geographic Origin
Show Location: ExCeL London, London, United Kingdom
Attendee Origin: Global, with strong representation from Europe, North America, Asia-Pacific, and emerging markets in Africa and Latin America.
Geographic Targeting:
- Europe (40%): UK, Germany, France, Netherlands
- North America (30%): USA, Canada
- Asia-Pacific (20%): China, Japan, South Korea, India
- Rest of World (10%): Australia, Middle East, Brazil
3️⃣ Audience Reach
Reach Type: Global, with a focus on fostering international collaboration in bioscience and engineering.
This conference attracts a diversified global audience, emphasizing knowledge exchange between academia, industry, and policymakers. Key themes include cross-border partnerships, regulatory harmonization, and global health challenges.
4️⃣ Sample Buyer Company Names + Websites
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | thermofisher.com | Director of Research Collaborations | Major supplier of lab equipment and reagents; actively partners with academic institutions. |
| 2 | Novartis Pharmaceuticals | novartis.com | VP of Biotechnology R&D | Invests heavily in innovative drug discovery and biotech partnerships. |
| 3 | Roche Diagnostics | roche.com | Head of Molecular Diagnostics | Leader in diagnostic technologies; seeks academic and industry collaborations. |
| 4 | CRISPR Therapeutics | crisprtherapeutics.com | Chief Scientific Officer | Pioneer in gene-editing technologies; attends to explore research partnerships. |
| 5 | University of Cambridge | cam.ac.uk | Dean of Biomedical Sciences | Academic leader seeking industry partnerships for translational research. |
| 6 | Bio-Rad Laboratories | bio-rad.com | Senior Marketing Manager, Life Science | Supplies tools for molecular biology and genomics; targets researchers and educators. |
| 7 | Moderna Therapeutics | modernatx.com | Director of mRNA Research | Focuses on mRNA-based therapies; engages with academic and biotech collaborators. |
| 8 | MIT-IBM Watson AI Lab | mit.edu | Principal Research Scientist, AI in Healthcare | Explores AI-driven solutions for bioscience challenges. |
| 9 | Ginkgo Bioworks | ginkgobioworks.com | VP of Synthetic Biology | Platform for organism engineering; partners with academia and industry. |
| 10 | WHO Collaborating Centre for Public Health | who.int | Chief Medical Officer | Interests in global health innovations and policy frameworks. |
| 11 | Agilent Technologies | agilent.com | Business Development Manager, Biopharma | Provides analytics and biopharma solutions; targets research institutions. |
| 12 | Stanford University School of Medicine | stanford.edu | Chair, Department of Bioengineering | Seeks industry partnerships for medical device innovation and translational research. |
| 13 | Lonza Group | lonza.com | Head of Biologics Development | Contract development and manufacturing organization (CDMO) for biopharmaceuticals. |
| 14 | Google Health | health.google.com | Lead Data Scientist, Digital Health | Focuses on AI and machine learning applications in healthcare. |
| 15 | King’s College London | kcl.ac.uk | Professor of Regenerative Medicine | Academic institution with strong ties to industry partners in biomedical engineering. |
Top 5 Best Samples to Prioritize: Thermo Fisher Scientific, Novartis Pharmaceuticals, CRISPR Therapeutics, Roche Diagnostics, and Ginkgo Bioworks. These represent core buyers in research tools, pharmaceuticals, synthetic biology, and diagnostics.
5️⃣ Job Profiles, Industries & Event Type
Best Job Profiles to Target:
- Chief Scientific Officer
- Director of Biotechnology R&D
- Professor of Bioengineering
- Head of Molecular Diagnostics
- VP of Business Development, Life Sciences
- Lab Director, Research Institute
- Principal Research Scientist
- Dean of Biomedical Sciences
Best Apollo Industries to Target:
- Biotechnology
- Pharmaceuticals
- Healthcare
- Research
- Education Management
- Higher Education
- Medical Devices
- Information Technology & Services (AI/ML in healthcare)
- Environmental Services
6️⃣ Estimated Attendance
- Total Expected Footfall: 1,500+ participants
- Researchers & Academics: 600+
- Industry Professionals: 500+
- Students & Postdocs: 300+
- Exhibitors & Sponsors: 100+
The event spans 4 days, featuring keynote speeches, technical sessions, poster exhibitions, and networking opportunities. Exhibitor booths focus on lab equipment, AI-driven healthcare solutions, and biotech innovations.
7️⃣ Key Focus Areas & Buyer Engagement
Key Themes:
- Genomics and Personalized Medicine
- Synthetic Biology and CRISPR Technologies
- AI and Machine Learning in Drug Discovery
- Biomedical Engineering and Medical Devices
- Sustainable Bioprocesses and Environmental Biotechnology
- Global Health Challenges and Pandemic Preparedness
Buyer Engagement Angle: Position your client’s product/service as a catalyst for innovation in bioscience and engineering. Highlight opportunities for collaboration, such as:
- Partnerships for co-developing research tools
- Licensing cutting-edge technologies
- Recruiting top-tier researchers and students
- Exhibiting next-generation lab equipment or software
8️⃣ Client-Product Fit Analysis
Please share your client’s website for a tailored analysis. Below are hypothetical scenarios based on common product categories:
- If your client sells lab automation equipment: Target titles like Lab Director, Principal Research Scientist, and Procurement Managers at institutions like Thermo Fisher, Agilent, or academic labs.
- If your client offers AI-driven drug discovery platforms: Focus on VP of R&D at Novartis, CRISPR Therapeutics, or Google Health.
- If your client provides bioprocessing services: Engage with CDMOs like Lonza Group or academic biotech partners.
- If your client is a recruitment firm: Target HR Directors at biotech firms or Deans of Science faculties.
9️⃣ Final Recommendation
BIEN 2026 is an excellent platform for connecting with buyers in bioscience and engineering. The event’s global reach and focus on innovation make it ideal for:
- Technology providers seeking academic or industry partnerships
- Pharmaceutical companies looking to collaborate on R&D
- Recruitment firms targeting top researchers and students
- Policy influencers shaping the future of biotechnology
Quality Rating for B2B Engagement: 9/10. Strong academic-industry mix, high buyer density, and a clear focus on innovation. Ensure targeting aligns with your client’s product lifecycle stage.
Data sheet
| Event Name | 9th International Conference on Bioscience & Engineering (BIEN 2026) |
| Event Date | 29–30 July 2026 |
| Event Status | Upcoming |
| Venue | Virtual Conference |
| City | Virtual / Online |
| State / Region | Not applicable |
| Country | Global / Virtual |
| Organizer | Not publicly confirmed in the provided brief |
| Official Event Website | Not provided in the request |
| Event Type | International academic and industry conference |
| Primary Category | Science & Research |
| Secondary Applicable Categories | Medical & Pharma; Industrial Engineering; Agriculture & Forestry; Environment & Waste; IT & Technology |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. Estimated: 300–800 virtual participants based on comparable international academic conference formats. |
| Attendance Data Reliability | Estimated only; no current-year official attendance figure provided |
| Main Purpose of Event | To share bioscience and engineering research, present innovations, build collaborations, support publication and academic networking, and connect researchers with industry and technology stakeholders. |
BIEN 2026 is positioned as an international bioscience and engineering conference focused on research exchange across biotechnology, healthcare technologies, environmental science, agricultural biotechnology, and applied engineering. As a virtual event, it removes geographic barriers and can attract a broad mix of academic, technical, and innovation-oriented participants from multiple regions.
The event is relevant to organizations seeking scientific collaboration, research visibility, technology scouting, and cross-sector partnerships. Typical participants include researchers, professors, students, biotech and pharma professionals, government or regulatory stakeholders, startup founders, and suppliers of laboratory, software, analytics, and healthcare technology solutions.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Academic researchers and principal investigators | Universities, research institutes, research hospitals | Influence on lab purchases, collaborations, grants, and technology evaluation | High for lab tools, software, instrumentation, reagents, and research services |
| Biotech and pharmaceutical R&D leaders | Biotech firms, pharma companies, CROs, CDMOs | Decision-makers for R&D platforms, analytics, automation, and outsourced services | High for product development, validation, and commercialization suppliers |
| Healthcare researchers and clinical specialists | Hospitals, clinical research groups, medical schools | Influence on diagnostics, digital health, and clinical technology evaluation | High for medtech, diagnostics, digital workflows, and data solutions |
| Government and regulatory stakeholders | Health agencies, science ministries, regulators, public labs | Policy, compliance, funding, and procurement influence | Medium to high for compliant research, public-sector, and grant-funded offerings |
| Startup founders and innovation teams | Biotech startups, medtech startups, university spinouts | Early-stage technology evaluation, partnership building, and vendor selection | High for software, CRO services, prototyping, and capital equipment |
| Equipment and laboratory technology buyers | Research labs, core facilities, biotech manufacturers | Direct purchasing authority or strong recommendation power | High for instrumentation, automation, lab informatics, and service contracts |
| Investors and commercialization advisors | VCs, angel groups, incubators, accelerators | Funding, market validation, and partnership influence | Medium for innovation, data platforms, and scaling solutions |
| Students and postdoctoral researchers | Universities, graduate programs, training institutes | Low direct buying power; high future influence and referral potential | Useful for academic software, training, and career development brands |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city / virtual access point | Global online audience; no single host-city concentration | Low | Virtual format expands reach beyond a physical venue |
| Home institutions in the United Kingdom | Universities, hospitals, research labs, biotech firms | Medium | Likely strong participation due to English-language format and academic relevance |
| Europe | UK, Germany, France, Netherlands, Nordics, Switzerland | High | Major bioscience and life-science research corridor |
| North America | United States, Canada | High | Strong concentration of biotech, pharma, university, and clinical research buyers |
| Asia-Pacific | India, China, Singapore, Japan, South Korea, Australia | High | Research-intensive and fast-growing biotech markets |
| Middle East, Africa, Latin America | Public health, academic, and applied research communities | Medium | Relevant for knowledge transfer, training, and research collaborations |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | Virtual international conference format supports participation from multiple continents and research ecosystems. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| University of Oxford | Research institution | Major bioscience, biomedical, and engineering research buyer | ox.ac.uk | PI, Lab Manager, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| University of Cambridge | Research institution | Deep life-science and bioengineering research purchasing needs | cam.ac.uk | Research Director, Lab Head, Sourcing Lead | Strong Market Fit, Attendance Not Confirmed |
| Imperial College London | Research institution | Engineering and biosciences convergence buyer | imperial.ac.uk | Head of Research, Procurement, Innovation Manager | Strong Market Fit, Attendance Not Confirmed |
| Harvard University | Research institution | Large interdisciplinary bioscience and engineering buyer base | harvard.edu | Research Admin, Lab Director, Category Manager | Strong Market Fit, Attendance Not Confirmed |
| Massachusetts Institute of Technology | Research institution | Engineering-led bioscience innovation and commercialization | mit.edu | Research Lead, Technology Transfer, Procurement | Strong Market Fit, Attendance Not Confirmed |
| Roche | Pharma / diagnostics | Potential buyer of research tools, diagnostics, and workflow technologies | roche.com | R&D Director, Lab Automation, Category Manager | Strong Market Fit, Attendance Not Confirmed |
| Novartis | Pharma | Large pharma R&D and digital science stakeholder | novartis.com | Director of R&D, Procurement Lead, Scientific Operations | Strong Market Fit, Attendance Not Confirmed |
| AstraZeneca | Pharma / biotech | Research-heavy organization with buying influence in science and engineering tech | astrazeneca.com | Procurement Manager, Scientific Director, Innovation Lead | Strong Market Fit, Attendance Not Confirmed |
| National Institutes of Health (NIH) | Government research organization | Public-sector bioscience research and funding influence | nih.gov | Program Officer, Contracting Officer, Scientific Program Lead | Strong Market Fit, Attendance Not Confirmed |
| Centers for Disease Control and Prevention (CDC) | Government health agency | Public health research, diagnostics, and surveillance technology interest | cdc.gov | Procurement Specialist, Lab Director, Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Scientific Officer / VP Research | Research & Development | C-level / VP | Sets research priorities and approves major technology investments |
| 2 | Director of Research / Lab Director | Scientific Operations | Director | Owns lab capabilities, equipment needs, and vendor evaluation |
| 3 | Procurement Manager / Strategic Sourcing Manager | Procurement | Manager | Purchasing authority for scientific, software, and service categories |
| 4 | Principal Investigator / Professor | Academia | Senior / Faculty | Influences grant-backed purchases, collaboration, and publication-driven adoption |
| 5 | Clinical Research Director | Clinical Development | Director | Evaluates trial support tools, diagnostics, and research collaboration tools |
| 6 | Head of Innovation / Technology Transfer | Innovation | Senior Manager / Director | Drives commercialization and partnership decisions |
| 7 | Bioprocess / Manufacturing Director | Operations / Manufacturing | Director | Relevant for scale-up, automation, and process engineering suppliers |
| 8 | Government Program Officer / Contracting Officer | Public Sector / Procurement | Manager / Senior | Influences funded research purchases and approved vendors |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Research | Core audience is research-led and publication-driven | Academic and applied research stakeholders |
| 2 | Biotechnology | Strong bioscience theme | Biotech R&D and innovation teams |
| 3 | Pharmaceuticals | Relevant for translational research and clinical applications | Pharma R&D and scientific operations |
| 4 | Medical Devices | Applicable to diagnostics and healthcare technologies | Diagnostics, medtech, and product teams |
| 5 | Hospital & Health Care | Clinical research and healthcare technology relevance | Clinical and operational buyers |
| 6 | Information Technology & Services | Data, software, AI, and research platforms are common enablers | Bioinformatics, data, and digital lab buyers |
| 7 | Government Administration | Public research and regulatory stakeholders may attend | Public-sector procurement and program staff |
| 8 | Higher Education | Primary source of academic attendees | University researchers, administrators, and lab managers |
| 9 | Environmental Services | Environmental bioscience and sustainability topics may be included | Environmental testing and monitoring buyers |
| 10 | Agriculture | Agricultural biotechnology relevance | Ag-bio innovation and applied science buyers |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | 300–800 | Estimated | Comparable international virtual academic conference formats | No organizer-confirmed attendance figure supplied |
| Exhibitor count | Not publicly confirmed | Unavailable | No official exhibitor directory provided | Virtual academic conferences may have limited exhibition structure |
| Buyer count | Not publicly confirmed | Unavailable | No official buyer list provided | Buyer profile inferred from event theme |
| Speaker count | Not publicly confirmed | Unavailable | No agenda/speaker list provided | Likely to include academic and industry presenters |
| Sponsor count | Not publicly confirmed | Unavailable | No sponsor list provided | Sponsorship likely limited if fully virtual |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Bioscience research | Tools, assays, workflows, collaboration | Scientific vendor discovery and research networking | Lab instruments, reagents, research services |
| Engineering innovation | Applied solutions and prototypes | Technology demos and partnership discussions | Automation, instrumentation, systems integration |
| Healthcare technologies | Diagnostics and clinical workflow improvement | Clinical and translational use-case validation | Digital health, diagnostics, lab software |
| Agricultural biotechnology | Crop, bio-input, and food science innovation | Cross-sector R&D and applied science discussions | Biotech platforms, analytics, testing services |
| Environmental science | Sustainability, testing, monitoring | Partnerships for environmental applications | Monitoring devices, environmental services, analytics |
| Research commercialization | Funding, licensing, market adoption | Startup and investor networking | Consulting, licensing support, data platforms |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Strong concentration of research, biotech, healthcare, and innovation stakeholders. |
| Decision-maker availability | Medium | Academic and research audiences may include many influencers rather than immediate purchasers. |
| Data collection potential | Medium | Virtual format can support registration capture, but no official list was provided. |
| Apollo targeting potential | Very High | Clear industry and title segmentation across research, biotech, pharma, and higher education. |
| Geographic targeting potential | High | Virtual event allows global targeting by region and research hub. |
| Best outreach approach | Thought leadership + research utility | Lead with scientific value, collaboration, and applied use cases rather than hard sales messaging. |
| Overall lead quality | High | Best for long-cycle B2B outreach, research partnerships, and specialist lead generation. |
| Best use case | List building and targeted outreach | Strong fit for academic, biotech, lab tech, and scientific software prospecting. |
| Limitations / risks | No official attendee list provided | Cannot confirm current-year companies, attendance volume, or sponsor/exhibitor mix. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Research; Biotechnology; Pharmaceuticals; Medical Devices; Hospital & Health Care; Information Technology & Services; Higher Education; Government Administration; Environmental Services; Agriculture | Align targeting with the event’s scientific and applied innovation themes |
| Departments | R&D; Procurement; Scientific Operations; Innovation; Clinical Development; Engineering; IT | Reach both buyers and influencers |
| Seniority | Manager; Director; VP; CXO; Senior Individual Contributor | Prioritize decision-makers and technical evaluators |
| Job titles | Chief Scientific Officer, VP Research, Director of Research, Lab Director, Procurement Manager, Strategic Sourcing Manager, Principal Investigator, Clinical Research Director, Head of Innovation, Technology Transfer Manager | Capture the highest-fit roles for scientific and procurement conversations |
| Geography | United Kingdom, Europe, United States, Canada, India, Singapore, Australia | Match the event’s global virtual reach |
| Employee size | 11–50; 51–200; 201–500; 501–1,000; 1,001+ | Cover startups, mid-market labs, and enterprise research organizations |
| Keywords | bioscience, biotechnology, bioengineering, genomics, proteomics, diagnostics, lab automation, research, clinical trial, bioinformatics, agricultural biotech, environmental science | Refine by topical relevance |
| Company type | Educational institutions; research institutes; public sector; biotech; pharma; medtech; startups | Focus on organizations most likely to evaluate or purchase research solutions |
| Revenue / funding | Optional: funded startups, public companies, grant-funded institutions | Useful for account prioritization and segmentation |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| User-provided event brief | Request-provided information | Event title, virtual venue, dates, and high-level thematic description | Moderate for the items explicitly supplied in the request |
| Event title and format inference | Analytical assessment | Likely audience profile, Apollo targeting, and category mapping | Estimated / interpretive; not official event data |
| Comparable virtual academic conference benchmarks | Market benchmark reference | Estimated attendance range for planning purposes | Estimated only; not organizer-confirmed |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 9th International Conference on Bioscience & Engineering (BIEN 2026) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.